The MicroThermX Microwave Ablation System includes a microwave generator, single-patient-use disposable antennas, and a thermistor-based temperature monitoring system.

The MicroThermX utilizes synchronous phased array technology to provide uniform zones of ablation during a single procedure.

The agreement provides the rights to market the MicroThermX line of products in the states of North Carolina, South Carolina, Georgia, Florida, Alabama and Tennessee.

BSD’s sales and marketing team is placed to manage the sales and distribution network, work with the sales representatives, assist in the selling process, and provide ongoing training and clinical support.

Further, the company’s MicroThermX has already received the US Food and Drug Administration’s marketing approval for ablation of soft tissue.